Treatments for carpal tunnel syndrome: who does what, when ... and why?
OBJECTIVE
To determine how frequently treatments had been offered to patients with suspected diagnoses of carpal tunnel syndrome (CTS) who had been referred for confirmatory nerve conduction studies (NCSs) and to identify potential predictors of such treatment. A follow-up survey was conducted to determine the effect of NCS results on subsequent treatment.


METHODS
Self-administered survey questionnaire and follow-up telephone survey.


METHODS
Royal University Hospital at the University of Saskatchewan in Saskatoon.


METHODS
Two hundred eleven patients with clinically suspected CTS who had been referred for confirmatory NCS.


METHODS
Results of NCSs, number of patients prescribed wrist splints or nonsteroidal anti-inflammatory drugs (NSAIDs) before and after NCSs, patient characteristics associated with being prescribed therapy, and reporting benefit of therapy.


RESULTS
Nerve conduction studies confirmed CTS in 121 (57.3%) of the 211 study patients. Before NCSs, wrist splints and NSAIDs had been prescribed to 33.2% and 38.8% of patients, respectively. Splints and NSAIDs were reported to alleviate symptoms by 78.3% and 74% of patients, respectively, who received such treatments. No significant differences in age, sex, body mass index, symptom duration, symptom or function scores, or subsequent NCS results were noted between patients who were and were not prescribed these therapies or between those who did or did not report improvement in symptoms. Results of the follow-up survey indicated that the number of recommendations for splints and NSAIDs had doubled after NCSs were completed and that surgical intervention had been at least discussed in most cases. Treatment recommendations, including surgery, however, were not associated with identifiable patient factors, including patients' NCS results.


CONCLUSIONS
Some patients were prescribed conservative treatments before NCSs. Following NCSs, prescriptions for wrist splints or NSAIDs approximately doubled. Interestingly, NCS results did not appear to influence subsequent therapeutic decision-making for either conservative treatment or surgical options. We think these findings suggest a lack of confidence in electrodiagnostic study results. It would be interesting to evaluate a larger population of primary care patients prospectively to examine further the use of NCSs in current clinical decision-making.
Taylor-Gjevre
Regina M
RM
Department of Medicine in the Royal University Hospital at the University of Saskatchewan in Saskatoon. r.gjevre@usask.ca
Gjevre
John A
JA
Strueby
Lannae
L
Boyle
Carol A J
CA
Nair
Bindu
B
Sibley
John T
JT
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002349:Carpal Tunnel Syndrome / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D019299:Decompression, Surgical / Q000379:methods*; D004568:Electrodiagnosis / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction; D010147:Pain Measurement; D017060:Patient Satisfaction / Q000706:statistics & numerical data; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D012525:Saskatchewan; D012720:Severity of Illness Index; D013165:Splints; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D025101:Vitamin B 6 / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D025101:Vitamin B 6